Stock Screener App

Frei -

Installieren

2.58

0.39% -0.010

after-market

Handel nachbörslich: 2.57 -0.01 -0.39%

Spero Therapeutics Inc (SPRO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Spero Therapeutics Inc-Aktie (SPRO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	61.65% 5.442	14.19	5.874	15.04	13.47
Operating Expenses	19.69% 13.36	16.63	20.61	36.77	32.06
Benefits Costs and Expenses	19.29% 12.82	15.89	19.74	116.54	-
Costs And Expenses	19.29% 12.82	15.89	19.74	31.97	32.06
Operating Income/Loss	223.90% -7.916	-2.444	-14.73	-21.73	-18.59
Nonoperating Income/Loss	28.23% 0.534	0.744	0.865	1.127	1.156
Income/Loss From Continuing Operations Before Tax	334.24% -7.382	-1.70	-13.87	-101.50	13.47
Income Tax Expense/Benefit	-	-	-	0.29	-0.29
Income/Loss From Continuing Operations After Tax	334.24% -7.382	-1.70	-13.87	-20.89	-17.15
Net Income/Loss	334.24% -7.382	-1.70	-13.87	-20.89	-17.15
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.45% 56.28	56.03	55.38	0.1681	54.12
Diluted Average Shares	0.45% 56.28	56.03	55.38	0.1681	54.12
Basic Earnings Per Share	333.33% -0.13	-0.03	-0.25	-0.38	-0.32
Diluted Earnings Per Share	333.33% -0.13	-0.03	-0.25	-0.38	-0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters